Can Chronic Nitric Oxide Inhibition Improve Liver and Renal Dysfunction in Bile Duct Ligated Rats?

Abstract EN

The aims of the present work were to study the effects of chronic NO inhibition on liver cirrhosis and to analyze its relationship with liver and kidney damage markers.

Two inhibitors of NO synthesis (inducible NO synthase (iNOS) inhibitor, aminoguanidine (AG), and nonselective NOS inhibitor, L-nitroarginine methyl ester (L-NAME)) were administered for 6 weeks to bile duct ligated (BDL) rats 3 days after surgery.

The present study showed that BDL was associated with liver injury and renal impairment.

BDL increased liver NO content and myeloperoxidase (MPO) activity.

This was corroborated by increased oxidative stress, TNF-α, TGF-1β, and MMP-13 genes overexpression.

Although both drugs reduced NO synthesis and TNF-α gene overexpression, only AG improved renal dysfunction and liver damage and reduced liver oxidative stress.

However, L-NAME exacerbated liver and renal dysfunction.

Both drugs failed to modulate TGF-1β and MMP-13 genes overexpression.

In conclusion, inhibition of NO production by constitutive nitric oxide synthase (cNOS) plays a crucial role in liver injury and renal dysfunction while inhibition of iNOS by AG has beneficial effect.

TNF-α is not the main cytokine responsible for liver injury in BDL model.

Nitric oxide inhibition did not stop the progression of cholestatic liver damage.